Dr. John Leahy, M.D

NPI: 1598859480
Total Payments
$152,041
2021 Payments
$6,000
Companies
6
Transactions
121
Medicare Patients
341
Medicare Billing
$35,100

Payment Breakdown by Category

Consulting$90,333 (59.4%)
Travel$47,659 (31.3%)
Other$10,625 (7.0%)
Food & Beverage$3,418 (2.2%)
Education$6.02 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $90,333 19 59.4%
Travel and Lodging $47,659 57 31.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,625 2 5.7%
Food and Beverage $3,418 41 2.2%
Honoraria $2,000 1 1.3%
Education $6.02 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme Corporation $67,821 66 $0 (2021)
Novo Nordisk Inc $35,842 32 $0 (2019)
Novo Nordisk AS $31,525 10 $0 (2018)
SANOFI-AVENTIS U.S. LLC $11,047 4 $0 (2017)
Janssen Scientific Affairs, LLC $5,801 8 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2021 $6,000 3 Merck Sharp & Dohme Corporation ($6,000)
2020 $3,600 2 Merck Sharp & Dohme Corporation ($3,600)
2019 $24,341 25 Merck Sharp & Dohme Corporation ($16,447)
2018 $53,036 37 Merck Sharp & Dohme Corporation ($18,762)
2017 $65,064 54 Merck Sharp & Dohme Corporation ($23,011)

All Payment Transactions

121 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
10/15/2021 Merck Sharp & Dohme Corporation Consulting Fee Cash or cash equivalent $2,200.00 General
10/15/2021 Merck Sharp & Dohme Corporation Consulting Fee Cash or cash equivalent $1,800.00 General
05/03/2021 Merck Sharp & Dohme Corporation Consulting Fee Cash or cash equivalent $2,000.00 General
11/04/2020 Merck Sharp & Dohme Corporation Consulting Fee Cash or cash equivalent $2,400.00 General
07/03/2020 Merck Sharp & Dohme Corporation Consulting Fee Cash or cash equivalent $1,200.00 General
12/07/2019 Novo Nordisk Inc Food and Beverage In-kind items and services $55.67 General
12/02/2019 Merck Sharp & Dohme Corporation Consulting Fee Cash or cash equivalent $1,200.00 General
05/29/2019 Merck Sharp & Dohme Corporation Consulting Fee Cash or cash equivalent $8,400.00 General
05/29/2019 Merck Sharp & Dohme Corporation Travel and Lodging Cash or cash equivalent $150.00 General
05/18/2019 Merck Sharp & Dohme Corporation Travel and Lodging In-kind items and services $88.51 General
05/17/2019 Merck Sharp & Dohme Corporation Travel and Lodging In-kind items and services $205.97 General
05/17/2019 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $41.94 General
05/17/2019 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $12.44 General
05/16/2019 Merck Sharp & Dohme Corporation Travel and Lodging In-kind items and services $205.97 General
05/16/2019 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $66.80 General
05/16/2019 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $41.94 General
05/16/2019 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $24.89 General
05/15/2019 Merck Sharp & Dohme Corporation Travel and Lodging In-kind items and services $205.97 General
05/15/2019 Merck Sharp & Dohme Corporation Travel and Lodging In-kind items and services $86.42 General
05/15/2019 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $65.59 General
05/14/2019 Merck Sharp & Dohme Corporation Travel and Lodging In-kind items and services $5,650.74 General
03/05/2019 Novo Nordisk Inc Consulting Fee Cash or cash equivalent $5,865.00 General
03/05/2019 Novo Nordisk Inc Travel and Lodging In-kind items and services $492.73 General
03/05/2019 Novo Nordisk Inc Food and Beverage In-kind items and services $467.49 General
03/05/2019 Novo Nordisk Inc Travel and Lodging In-kind items and services $394.86 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 2 31 32 $4,058 $2,531
2020 5 310 532 $75,281 $32,569
Total Patients
341
Total Services
564
Medicare Billing
$35,100
Procedure Codes
7

All Medicare Procedures & Services

7 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 14 14 $2,070 $1,269 61.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 17 18 $1,988 $1,262 63.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 157 247 $22,100 $12,750 57.7%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 39 126 $29,302 $7,118 24.3%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2020 57 86 $11,004 $6,134 55.7%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 44 60 $7,380 $5,178 70.2%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 13 13 $5,495 $1,389 25.3%

About Dr. John Leahy, M.D

Dr. John Leahy, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Burlington, Vermont. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598859480.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Leahy, M.D has received a total of $152,041 in payments from pharmaceutical and medical device companies, with $6,000 received in 2021. These payments were reported across 121 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($90,333).

As a Medicare-enrolled provider, Leahy has provided services to 341 Medicare beneficiaries, totaling 564 services with total Medicare billing of $35,100. Data is available for 2 years (2020–2022), covering 7 distinct procedure/service records.

Practice Information

  • Specialty Endocrinology, Diabetes & Metabolism
  • Other Specialties Diabetes & Metabolism
  • Location Burlington, VT
  • Active Since 10/03/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207RE0101X
  • Entity Type Individual
  • NPI Number 1598859480

Products in Payments

  • FIASP (Drug) $13,486
  • SOLIQUA (Drug) $11,047
  • INVOKANA (Drug) $5,801

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Endocrinology, Diabetes & Metabolism Doctors in Burlington